Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company with a market capitalization of $446.4 million specializing in mRNA therapeutics and vaccines, stands at a ...

BTIG analysts began covering Arcturus Therapeutics (NASDAQ:ARCT) with a positive outlook, assigning a Buy rating and establishing a price target of $41.00. Currently trading at $16.49 with a market ...

HHS said Moderna will develop and assess an mRNA vaccine against H7N9 avian influenza in a phase 3 clinical trial. The company will also design up to four other novel pandemic flu vaccines and do the ...

Arcturus Therapeutics Holdings Inc. stock is down 46% since Sept. 2023 coverage; mRNA sector faces headwinds with public ...

A collaboration between the Ragon Institute and the Jameel Clinic at MIT has achieved a significant milestone in leveraging ...

Here we have listed the best smartphones that let you experience AI capabilities to the fullest. Without any delays, here are the best AI-Powered mobiles (January 2025) that make the cut: Read More ...

Mexico’s first female president On October 1, Claudia Sheinbaum became Mexico’s first female and Jewish president, making history. In a nation where women were granted the right to vote only in 1953, ...